New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For CI;WCG;HNT;MOH;UNH;CVH;WLP;AGP;CNC;HS;HUM;AET;MDT;BSX;STJ From The Last 14 Days
Check below for free stories on CI;WCG;HNT;MOH;UNH;CVH;WLP;AGP;CNC;HS;HUM;AET;MDT;BSX;STJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
April 10, 2014
15:56 EDTWCG, WLPWellCare rumored to be takeover target, Betaville blog says
Wellcare (WCG) which has previously been speculated as a takeover target by analysts, is being studied as a target by Wellpoint (WLP), according to the Betaville blog, which cites sources familiar with the matter. Shares of WellCare, which have been lower throughout the session, briefly spiked following the blog post, but have returned to negative territory in late afternoon trading. Reference Link
15:52 EDTWCGWellCare rumored to be takeover target, Betaville blog says
Subscribe for More Information
April 8, 2014
11:02 EDTHUMHumana now sees 2015 CMS Medicare Advantage funding decline of 3%
Subscribe for More Information
10:18 EDTWLP, UNH, CI, HUM, AET, WCG, HNTCMS says Medicare Advantage reimbursement to rise in 2015
Subscribe for More Information
09:23 EDTWCG, CI, CNC, HNT, UNH, WLP, HUM, AET, MOHLeerink views final rates as favorable for MA plans
Subscribe for More Information
07:26 EDTMDTElsevier Business Intelligence to hold a conference
Subscribe for More Information
April 7, 2014
19:13 EDTWLP, AGP, CI, UNH, AET, WCG, MOH, HUM, HS, HNT, CNCCMS issues 2015 rate announcement for Medicare Advantage and Part D programs
Subscribe for More Information
18:01 EDTBSXBoston Scientific gets FDA, CE Mark clearance for Expect Slimline Needle
Boston Scientific announced it has received clearance from the U.S. FDA and CE Mark approval in Europe for the Expect Slimline Needle, which is now globally available for Endoscopic Ultrasound-Fine Needle Aspiration procedures. The Expect Slimline Needle is on contract with four leading group purchasing organizations.
10:02 EDTCICigna announces first collaborative care program in South Florida
Subscribe for More Information
07:58 EDTMDTMedtronic data positive for C.R. Bard, says Barclays
Barclays said Medtronic's (MDT) better than expected drug coated balloon data could have a positive class effect that benefits C.R. Bard (BCR). The firm reiterates its Overweight rating C.R. Bard and raised its price target to $165 from $160. Note that BofA/Merrill downgraded C.R. Bard to Neutral from Buy following the Medtronic's news.
07:38 EDTMDTMedtronic data should lead to approval of drug-coated balloon, says Wells Fargo
Subscribe for More Information
April 4, 2014
08:08 EDTSTJSt. Jude Medical announces FDA approval of Protege IPG
Subscribe for More Information
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use